0001179110-14-008677.txt : 20140516
0001179110-14-008677.hdr.sgml : 20140516
20140516173352
ACCESSION NUMBER: 0001179110-14-008677
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140514
FILED AS OF DATE: 20140516
DATE AS OF CHANGE: 20140516
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABIOMED INC
CENTRAL INDEX KEY: 0000815094
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042743260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 22 CHERRY HILL DR
CITY: DANVERS
STATE: MA
ZIP: 01923
BUSINESS PHONE: 9787775410
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weber David M
CENTRAL INDEX KEY: 0001399519
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09585
FILM NUMBER: 14852661
BUSINESS ADDRESS:
BUSINESS PHONE: 925-600-8826
MAIL ADDRESS:
STREET 1: 2341 ROMANO CIRCLE
CITY: PLEASANTON
STATE: CA
ZIP: 94566
4
1
edgar.xml
FORM 4 -
X0306
4
2014-05-14
0
0000815094
ABIOMED INC
ABMD
0001399519
Weber David M
C/O ABIOMED, INC.
22 CHERRY HILL DRIVE
DANVERS
MA
01923
0
1
0
0
Chief Operating Officer
Common Stock, $.01 par value
2014-05-14
4
A
0
5000
0
A
131907
D
Common Stock, $.01 par value
2014-05-15
4
S
0
1425
20.9440
D
130482
D
Stock Option (right to buy)
13.88
2008-04-23
2017-04-23
Common Stock
130000
130000
D
Stock Option (right to buy)
13.80
2009-05-23
2018-05-23
Common Stock
12000
12000
D
Stock Option (right to buy)
5.86
2010-05-28
2019-05-28
Common Stock
6500
58500
D
Stock Options (right to buy)
5.86
2010-03-31
2019-05-28
Common Stock
34500
34500
D
Stock Option (right to buy)
10.03
2011-06-03
2020-06-03
Common Stock
50000
50000
D
Stock Option (right to buy)
22.44
2013-05-22
2022-05-22
Common Stock
25000
25000
D
Stock Option (Right to Buy)
23.15
2014-05-14
2023-05-14
Common Stock
23000
23000
D
Stock Option (Right to Buy)
21.55
2014-05-14
4
A
0
15000
0
A
2015-05-14
2024-05-14
Common Stock
15000
15000
D
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
This option becomes exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
Sale of common stock pursuant to reporting owner's 10b5-1 plan sold to pay tax obligations upon vesting.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $20.6200 and $21.4000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 14, 2015, May 14, 2016 and May 14, 2017, so long as the reporting person continues to be employed by the issuer on the vesting dates.
In addition, performance share awards of up to 11,250 restricted units were granted to this reporting person on May 14, 2014. The number of restricted stock units that will become eligible for vesting pursuant to this award will be determined based on the issuer's fiscal 2015 financial performance. One third of the restricted stock units that become eligible for vesting will vest on the date the issuer first publicly announces its financial results for fiscal 2015. The remaining restricted stock units that become eligible for vesting will vest and the underlying shares will be delivered to the reporting person in equal tranches on each of May 14, 2016 and May 14, 2017, in all cases, so long as the reporting person continues to be employed by the issuer on the vesting dates.
In addition, performance share awards of up to 18,000 restricted units were granted to this reporting person on May 14, 2014. One half of these restricted stock units will vest immediately upon the issuer's achievement of certain regulatory milestones within three years of the date of grant, with the remaining vesting on the first anniversary of such achievement.
These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
/s/ Stephen C. McEvoy (by power of attorney)
2014-05-16
EX-24
2
ex24weber.txt
LIMITED POWER OF ATTORNEY
The undersigned does hereby appoint each of
Stephen C. McEvoy, Ian W. McLeod, and Loretta Wedge,
signing singly, the undersigned's true and lawful
attorney-in-fact to:
(1) execute for and on behalf of the
undersigned, in the undersigned's capacity as a
director or officer of ABIOMED, Inc. (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a) of
the Securities Exchange Act of 1934 and the rules
thereunder;
(2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary or
desirable to complete and execute any such Form 3, 4
or 5 and timely file such form with the United States
Securities and Exchange Commission and any stock
exchange or similar authority; and
(3) take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall
be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in
such attorney-in-fact's discretion.
The undersigned hereby grants to each such
attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the
exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-
fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by
virtue of this power of attorney and the rights and
powers herein granted. The undersigned acknowledges
that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are
not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section
16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force
and effect until the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in
securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this power of attorney has
been executed as of the 29th day of May, 2009 and
shall remain in full force and effect until withdrawn
by the undersigned in writing.
Signature: /s/ David M Weber
Print Name: David M Weber